Community Home

Upcoming Events

Latest Shared Files

Community Blogs

  • Dr. Michael T. Lotze is Incoming Editor-in-Chief for the Journal for ImmunoTherapy of Cancer ( JITC ). As he transitions into his role with JITC , learn more about Dr. Lotze’s career, interest in JITC , and personal life. Career ...

  • The following articles have been recommended for further reading in the field of cancer immunotherapy by JITC 's Immune Cell Therapies and Immune Cell Engineering Section Editor Dr. Marcela Maus . “A versatile CRISPR-Cas13d platform ...

  • MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated to improving patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce their collaboration ...

    1 person recommends this.
  • The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest advances in immunotherapy emerging from the 2024 AACR Annual Meeting. Below is a recap of highlighted research presented from Friday, April 5–Wednesday, April ...

    2 people recommend this.
  • SITC and ACCC have collaborated on a new webinar aimed at providing further details on the Expanding Access to Cellular and Bispecific Therapy Workshop. This webinar featured expert speakers that provided perspective and thoughts on how to further access ...